Released June 15th, 2021
Matthew Harrison, Jason Kelly - Moderna: The Software of Life
Jason Kelly is the CEO of Gingko Bioworks and Matthew Harrison is a biotech analyst at Morgan Stanley. We cover the history of programming cells, what differentiates Moderna from other biotech companies, and lessons for entrepreneurs and investors can takeaway from Moderna's story.
Public Equity
Business Building
Technology
00:00:00
Subscribe:
Want to dive deeper? Check out Blocks - the best content to keep learning on any topic. Curated by Colossus®.
You must be logged in to view this content. Don't have an account? Register here. (It's free)

We plan to make Colossus a more interactive experience. Registration is step one in that process.